DK146974C - Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol - Google Patents

Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Info

Publication number
DK146974C
DK146974C DK535774A DK535774A DK146974C DK 146974 C DK146974 C DK 146974C DK 535774 A DK535774 A DK 535774A DK 535774 A DK535774 A DK 535774A DK 146974 C DK146974 C DK 146974C
Authority
DK
Denmark
Prior art keywords
dinatrum
carboxychromon
yloxy
inhaling
propan
Prior art date
Application number
DK535774A
Other languages
English (en)
Other versions
DK535774A (da
DK146974B (da
Inventor
Donald Ross Macarthur
David Ernest Smith
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36763080&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK146974(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to DK535774A priority Critical patent/DK146974C/da
Publication of DK535774A publication Critical patent/DK535774A/da
Publication of DK146974B publication Critical patent/DK146974B/da
Application granted granted Critical
Publication of DK146974C publication Critical patent/DK146974C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK535774A 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol DK146974C (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Applications Claiming Priority (12)

Application Number Priority Date Filing Date Title
GB3745671 1971-08-10
GB3745671A GB1410588A (en) 1971-08-10 1971-08-10 Composition
DK392872 1972-08-09
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
ZA7300284 1973-01-15
ZA730284A ZA73284B (en) 1971-08-10 1973-01-15 Pharmaceutical powder composition containing sodium cromoglycate
AU5119173 1973-01-17
AU51191/73A AU5119173A (en) 1971-08-10 1973-01-17 Composition
ES410910 1973-01-24
ES410910A ES410910A1 (es) 1971-08-10 1973-01-24 Un procedimiento para la preparacion de una composicion farmaceutica en polvo para inhalacion.
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol
DK535774 1974-10-11

Publications (3)

Publication Number Publication Date
DK535774A DK535774A (da) 1975-06-02
DK146974B DK146974B (da) 1984-03-05
DK146974C true DK146974C (da) 1984-08-13

Family

ID=36763080

Family Applications (2)

Application Number Title Priority Date Filing Date
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK535774A DK146974C (da) 1971-08-10 1974-10-11 Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK392872A DK131891C (da) 1971-08-10 1972-08-09 Fremgangsmade til fremstilling af et pulverpreparat til inhalation

Country Status (19)

Country Link
US (1) US4009280A (da)
JP (1) JPS5652001B2 (da)
AT (1) AT333974B (da)
AU (1) AU5119173A (da)
CA (1) CA992461A (da)
DE (1) DE2239091A1 (da)
DK (2) DK131891C (da)
ES (1) ES410910A1 (da)
FI (1) FI56487C (da)
FR (1) FR2150759B1 (da)
GB (1) GB1410588A (da)
IE (1) IE37102B1 (da)
IL (1) IL39990A (da)
LU (1) LU66875A1 (da)
NL (1) NL7210780A (da)
NO (1) NO140747C (da)
SE (1) SE411842B (da)
ZA (1) ZA73284B (da)
ZM (1) ZM11971A1 (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5042826A (da) * 1973-08-20 1975-04-18
JPS5042819A (da) * 1973-08-20 1975-04-18
JPS5042827A (da) * 1973-08-20 1975-04-18
JPS6019043B2 (ja) * 1975-12-11 1985-05-14 ソニー株式会社 磁気再生装置
JPS5313111U (da) * 1976-07-16 1978-02-03
US4238502A (en) * 1978-08-03 1980-12-09 Fisons Limited Method of treating psychiatric conditions
BE891013A (fr) * 1980-11-05 1982-05-05 Fisons Ltd Compositions pharmaceutique
DE3636209A1 (de) * 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9404945D0 (en) 1994-03-15 1994-04-27 Glaxo Group Ltd Pharmaceutical composition
DE4425255A1 (de) 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5747002A (en) * 1995-04-05 1998-05-05 Genentech, Inc. Preparation of sodium chloride aerosol formulations
US5985309A (en) * 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US6652837B1 (en) 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US20020052310A1 (en) * 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US20060165606A1 (en) * 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6309623B1 (en) * 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
ATE239447T1 (de) † 1997-09-29 2003-05-15 Inhale Therapeutic Syst In verneblern verwendbare, stabilisierte zubereitungen
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6956021B1 (en) * 1998-08-25 2005-10-18 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7678364B2 (en) 1999-08-25 2010-03-16 Alkermes, Inc. Particles for inhalation having sustained release properties
CA2382821A1 (en) * 1999-08-25 2001-03-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US20010036481A1 (en) * 1999-08-25 2001-11-01 Advanced Inhalation Research, Inc. Modulation of release from dry powder formulations
US6749835B1 (en) 1999-08-25 2004-06-15 Advanced Inhalation Research, Inc. Formulation for spray-drying large porous particles
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US8404217B2 (en) * 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
WO2002009674A2 (en) * 2000-07-28 2002-02-07 Inhale Therapeutic Systems, Inc. Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
US20020141946A1 (en) * 2000-12-29 2002-10-03 Advanced Inhalation Research, Inc. Particles for inhalation having rapid release properties
AU2002230993B2 (en) * 2000-12-29 2006-02-02 Alkermes, Inc. Particles for inhalation having sustained release properties
PL365736A1 (en) * 2001-02-06 2005-01-10 Innovata Biomed Limited Bimodal dry powder formulation for inhalation
WO2003043585A2 (en) * 2001-11-20 2003-05-30 Advanced Inhalation Research, Inc. Improved particulate compositions for pulmonary delivery
AU2002346472A1 (en) * 2001-11-20 2003-06-10 Advanced Inhalation Research, Inc. Particulate compositions for improving solubility of poorly soluble agents
JP2005514393A (ja) * 2001-12-19 2005-05-19 ネクター セラピューティクス アミノグリコシドの肺への供給
US6889690B2 (en) * 2002-05-10 2005-05-10 Oriel Therapeutics, Inc. Dry powder inhalers, related blister devices, and associated methods of dispensing dry powder substances and fabricating blister packages
US7763280B2 (en) * 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
US20070031342A1 (en) * 2005-06-22 2007-02-08 Nektar Therapeutics Sustained release microparticles for pulmonary delivery
EP2307589B1 (en) * 2008-07-24 2018-12-19 L'Air Liquide Société Anonyme pour l'Etude et l'Exploitation des Procédés Georges Claude Method for deposition of transition metal-containing films using heteroleptic cyclopentadienyl transition metal precursors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121096A (en) * 1961-12-27 1964-02-11 Roussel Uclaf New process of preparation of 3-methyl chromone
US3686412A (en) * 1965-03-25 1972-08-22 Colin Fitzmaurice Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1147976A (en) * 1965-12-21 1969-04-10 Fisons Pharmaceuticals Ltd Chromone derivatives
GB1190194A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
GB1223690A (en) * 1967-10-17 1971-03-03 Fisons Pharmaceuticals Ltd Substituted chromon-2-carboxylic acids
GB1292601A (en) * 1968-10-30 1972-10-11 Fisons Pharmaceuticals Ltd Bis-(2-carboxy-chromone) compounds, their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
FR2150759B1 (da) 1975-10-31
LU66875A1 (da) 1973-03-23
GB1410588A (en) 1975-10-22
JPS5652001B2 (da) 1981-12-09
AU5119173A (en) 1974-07-18
SE411842B (sv) 1980-02-11
IL39990A0 (en) 1972-09-28
ZM11971A1 (en) 1973-02-21
NL7210780A (da) 1973-02-13
NO140747B (no) 1979-07-30
CA992461A (en) 1976-07-06
ATA39073A (de) 1976-04-15
DK131891B (da) 1975-09-22
FI56487C (fi) 1980-02-11
DK131891C (da) 1976-02-23
AT333974B (de) 1976-12-27
ZA73284B (en) 1973-11-28
FI56487B (fi) 1979-10-31
IL39990A (en) 1977-02-28
DK535774A (da) 1975-06-02
ES410910A1 (es) 1976-07-16
DE2239091A1 (de) 1973-02-22
FR2150759A1 (da) 1973-04-13
DK146974B (da) 1984-03-05
US4009280A (en) 1977-02-22
NO140747C (no) 1979-11-07
JPS4826764A (da) 1973-04-09
IE37102B1 (en) 1977-05-11

Similar Documents

Publication Publication Date Title
DK146974C (da) Fremgangsmaade til fremstilling af et pulver til inhalation af dinatriumsaltet af 1,3-bis(2-carboxychromon-5-yloxy)propan-2-ol
FI52277C (fi) Hengitysnaamari, etenkin tekohengitystä varten.
NL187193C (nl) Inhaleringsapparaat voor poedervormige medicamenten.
DK156876C (da) Fremgangsmaade til fremstilling af en farmaceutisk komposition indeholdende 1,3-bis(2-carboxychromon-5-yloxy)-propan-2-ol
SE7601257L (sv) Bensoylureido-difenyletrar till anvendning som insekticider och sett att framstella dessa
DK134970B (da) Fremgangsmåde til fremstilling af et til inhalering beregnet farmaceutisk middel i pulverform.
SE433804B (sv) Forfarande for framstellning av en farmaceutisk lekemedelsberedning i kapselform med retardeffekt
DK562276A (da) Fremgangsmaade til fremstilling af en farmaceutisk administrationsform
SE7601258L (sv) Bensoylureido-nitro-difenyletrar till anvendning som insekticider och sett att framstella dessa
SE7504882L (sv) Forfarande for framstellning av ett nytt farmaceutiskt preparat.
SE7708563L (sv) Nya 0-etyl-s-n-propyl-0,2,2,2-trihalogenetylfosfortiolater (och-tionotiolater) till anvendning som insekticider, akaricider och nematocider och sett att framstella foreningarna
SE7609466L (sv) Nya fenotiazinderivat, anvendning derav som lekemedel och sett for deras framstellning
SE7513013L (sv) Sett att framstella 5,7-dihydroxi-tetrahydroisokinolinderivat och anvendning derav som lekemedel
DK135284B (da) Fremgangsmåde til fremstilling af 1,3-bis(halomethyl)phenobarbitaler.
DK135167B (da) Analogifremgangsmåde til fremstilling af 7,7'-ditheophyllinderivater.
DK137118B (da) Fremgangsmade til fremstilling af et lh-rh-preparat til nasal applikation
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
MX5355E (es) Procedimiento para la preparacion del hemicetal 3 a alfa-h-4-alfa(3'-propanol)-7-a beta-metilhexahidro-1,5-indandiona
DK132329C (da) Fremgangsmade til fremstilling af cardenolid-3,alfa-(2'-desoxy-glycosider)
SE7803069L (sv) Forfarande for framstellning av nya salter av 1,3-bis (2-karboxikromon -5-yloxi) propan-2-ol
SE385302B (sv) Sett att framstella 5-aminometyl-6-karbetoxi-oxazino(5',6'e)indolderivat
SE7602500L (sv) Nya 1,3-bensodioxanprostansyraderivat och sett att framstella desamma
SE7607220L (sv) Tennhaltiga triazino-bensimidazoler till anvendning som inselticider, akaricider och fungicider och sett for deras framstellning
SE7511626L (sv) Sett att framstella 2-substituerade 5-oxo-5h-dibenso-(a,d)-cykloheptener och anvendning derav som lekemedel
AR192794A1 (es) Un procedimiento de preparacion de derivados de(trimetoxi-3',4',5')cinamoil-1-carbonilmetil-4-piperazina

Legal Events

Date Code Title Description
PBP Patent lapsed